NCT02673333 2026-04-06Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical CarcinomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting39 enrolled 7 charts
NCT05036434 2026-01-23ACCOMPLISHNational Cancer Center, KoreaPhase 2 Active not recruiting30 enrolled